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Abstract
Angiography (mostly computed tomography, but in some cases, conventional) is still the 
gold diagnostic standard in the clinical diagnosis of pulmonary embolism (PE). Computer-
aided detection (CAD) is software that alerts radiologists the presence of PE during com-
puterized tomography pulmonary angiography (CTPA) examinations. Interpreting CTPA 
scans with the aid of commercially available CTPA-CAD has improved the detectability 
of PE patients. This chapter aims to complete the scope of this book by explaining the 
clinical evidences of PE, the CTPA technology, the role of CTPA-CAD software in improv-
ing the diagnostic abilities of CTPA and the role of conventional pulmonary angiography 
in daily clinical practice. The reader will be introduced to the performance of diagnosing 
PE with or without the aid of CTPA-CAD algorithms. Differences among CTPA-CAD’s 
output will be compared and tabled according to “per patient,” “per clot,” “first reader,” 
and “second reader” basis. This includes, but not limited to, the CTPA-CAD’s sensitivity 
and specificity in comparison to human observer performance (i.e., radiologist). These 
topics cover the current status practice at the pulmonary angiography clinic.
Keywords: computer-aided detection, computerized tomography pulmonary 
angiography, pulmonary embolism, digital image processing, conventional pulmonary 
angiography
1. Introduction
Computer sciences have reached medicine [1]. This includes developing algorithms to 
participate in the clinical interpretation of medical images acquired from various medical 
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
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imaging systems [2, 3]. These algorithms are categorized into two main groups. They are the 
computer-aided detection (CAD) and the computer-aided diagnosis (CADx) [2, 3]. Both of 
them employ principles of digital image processing (DIP).
Pulmonary embolism (PE) is the partial or complete blockage of one or some of pulmonary 
arteries; it is a life threatening disease with a challenging diagnosis [4]. In Europe and the USA, 
it leads to high incidence of mortality, morbidity, and hospitalization [4, 5]. Internationally, 
PE is expected to become the third leading cause of death by 2030 according to clinical projec-
tions on disease mortality [6]. Computerized tomography pulmonary angiography (CTPA) 
has become the first-line imaging examination to detect the occurrence of PE [4, 7–9]. Clinical 
trials of CTPA examination, without the aid of CAD, reported that the sensitivity and speci-
ficity CTPA scan may not reach 100% [8, 10]. This indicates that misdiagnoses, which are a 
prospective health burden and potential life threatening, may occur.
This chapter describes the current state of PE diagnosis in CTPA clinic, with and without the 
use of CAD algorithms. The chapter is divided into three main sections. Section 2 presents 
all clinical evidences about the PE as a disease that threaten lives. This covers the PE epide-
miology, incidence rate, characterizations, load scores, diagnosis, and treatment. Section 3 is 
dedicated to explain the CTPA physics and technology, image appearance, PE radiographic 
features, clinical trials, and common artifacts. Section 4 explains the art of computer-assisted 
detection and its applications in diagnosing PE. This demonstrates the role of CAD software 
in improving the PE diagnosis. In general, this chapter provides the up-to-date knowledge of 
PE diagnosis in angiography clinics.
2. Pulmonary embolism
2.1. Definition
Pulmonary embolism (PE) occurs when a blood clot, also known as a thrombus or embolus, 
arrives to pulmonary arteries. The source of thrombus is likely to be large veins of the lower 
extremity before it migrates through venous system to reach first the right heart chambers 
and later the lungs (Figure 1). Once a clot arrives to pulmonary arterial tree, it travels in 
the arteries of the lung until it blockades vessel/s that is/are too narrow to continue further. 
Thus, PE happens (Figure 1) leading to pulmonary blood flow shortage. Consequently, this 
condition associates with rise in the artery pressure due to the increased resistance to the 
bloodstream, shortness of breath, chest pain, and breathing difficulties; it can also lead to 
infarct or decrease in cardiac output, which in turn can cause hemodynamic disturbances, 
heart failure or even death [4, 5, 11, 12]. The common risk factors for PE are immobility or 
inactivity, hypertension, surgery or trauma, cigarette smoking, obesity, heart failure, cancer, 
chronic obstructive lung disease, hormone therapy, pregnancy, and advanced age and family 
members with thrombosis or embolism [4, 5, 12].
2.2. Incidence
Clinical surveys showed that the PE exhibits the highest incidence of mortality, morbidity, 
and hospitalization [4, 5, 13, 14]. The incidence of PE vary from one country to other but this 
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variation is likely attributed to the type and accuracy of the diagnostic procedure rather than 
the actual incidence of the disease itself [6, 15–18]. Annually, there are 430,000 and 300,000 
to 600,000 PE conditions in Europe and the USA, respectively [15, 16]. Globally, the clinical 
projections of mortality estimate that the incidence of PE will be the third major cause of 
death in year 2030 [6]. In Europe and the USA, autopsy investigations on hospitalized patients 
showed a PE prevalence from 60 to 70% [4, 5]. Therefore, the precise detection and diagnosis 
are highly desirable [4, 5].
2.3. Characterization
Embolus is characterized as central or peripheral, based on the site of the affected blood vessel 
branch [4]. Central vascular regions include the left and right main pulmonary arteries (PA), 
the right and left interlobar arteries, the right and left lobar arteries, and right and left lobar 
veins (Figure 1). Peripheral vascular regions include the remaining blood vessels in the upper, 
middle, and lower lobes of the right lung; and the upper and lower lobes in the left lung. This 
includes all the segmental, subsegmental, and intralobular arteries and veins including the 
culmen and the lingual (Figure 1).
Once a thrombus has been identified in the PA, it is further characterized as acute or chronic, 
as illustrated in Figure 2 [4]. In some cases, there is doubt between those two classes, depend-
ing on diagnosis procedure and experience of the observer. A clot in PA is usually considered 
as being “acute” if it is located centrally within the vascular lumen. This may lead to vessel 
dilation. However, a clot in PA is characterized as “chronic” when it appears contiguous to 
Figure 1. Pulmonary embolism pathophysiology.
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the vessel wall substantially reducing the arterial diameter. A clot that exhibits caves or canals 
within itself is also considered as “chronic.”
2.4. Load scores
Several scoring systems have been introduced to measure the severity of the PE clinic. For 
central PE, physicians utilize the Walsh, Miller, Qanadli, or Mastora score. While for periph-
eral PE, they use Marder, Arnesen, Mewissen (American Venous Registry), Porter, Ouriel, or 
Bjorgell scores. They are well summarized by Ghaye et al. [19, 20]. All these scores depend on 
the number of clots, location, and the percentage of obstruction. They all verified appropriate 
for assessing the severity of PE and treatment effectiveness, but are not much used in angiog-
raphy clinics due to time it takes to manually assess them.
2.5. Diagnosis
Diagnosing PE remains a challenge to physicians because the symptoms are unspecific and 
may not be present in all patients. The PE symptoms and risk factors (Section 2.1) are used 
to determine the probability of PE. Although biomarkers and laboratory tests are crucial to 
estimate the probability of PE, such as the electrocardiogram (ECG) and the measurement 
of percentage of cross-linked fibrin in the blood (D-dimer), the diagnostic decision is always 
based on radiographic findings from medical imaging procedures [4]. Different medical 
imaging techniques exist to “rule in” or “rule out” the presence of the PE. Each technique 
exhibits its strength and weakness and a shift toward the computerized tomography (CT) has 
been approved.
A planner chest X-ray remains the first imaging step because it can rule out the conditions that 
mimic PE (e.g., a pneumothorax can cause chest pain similar to pain caused by acute PE), but 
it cannot exclude PE. Another X-ray imaging test is the lower extremity venous angiography, 
in which contrast media is injected via a foot vein, and several X-ray projections contrast-
filled leg veins are taken [4]. The leg veins are “opacified” with contrast media, indicating the 
site of blood flow obstruction due to thrombosis. In both diagnosis situations, that is venous 
thrombosis is ruled in or out, further medical imaging tests are required to assess the decision 
of PE, which implies burden and probably additional radiation dose to patient.
Nuclear medicine techniques (e.g., pulmonary ventilation perfusion scintigraphy) permit the 
visualization of the distribution of a radioactive substance (i.e., radiopharmaceutical) through 
planner gamma camera or single photon emission computerized tomography (SPECT) [21, 
22]. In this technique, after the administration of gamma ray isotope tracer, the observation of 
airways and pulmonary blood vessels activity is made, hence the name, ventilation/perfusion 
Figure 2. Illustration of acute and chronic PE.
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(V/Q) scan. This scan remained as the traditional preferred imaging technique before the 
shift toward CT [4]. A mismatch of ventilated but not perfused lung tissue was considered as 
indicator for pulmonary embolism. Thus, it is indirect detection of an embolus by looking at 
the effects of an occlusion. A normal perfusion scan securely excluded pulmonary embolism, 
but was found in a minority of the patients that are suspected of PE, and thus, often further 
testing was needed [4]. The advantages of V/Q scan are that it is not invasive and less irradi-
ant than CT, and may be more suitable for patients that are allergic to iodinated agents (CT). 
Its disadvantage is that the obtained image determines only regions of the lungs that are 
not correctly vascularized, nonobstructing “small” clots remaining invisible [4]. Moreover, 
the duration of the exam is in the order of 20 min, which is slower than other modalities. 
Several reports showed that the CT scan outweigh the V/Q scan by performing both lower 
rate of false-negative scans and lower number of “indeterminate scans” not yielding a definite 
diagnosis [4, 22].
The sequence of chest X-ray projections during the administration of contrast agent directly 
into the target vessels, also called as pulmonary angiography, is a reliable test for diagnosing 
PE. In this imaging scan, a catheter is inserted into a femoral vein and navigated through 
the heart toward the pulmonary arteries. Amounts of contrast media is injected several 
times at various locations of pulmonary vessels, and sequence of X-ray planner projections 
are obtained. It is used to provide a definitive diagnosis when other imaging tests fail [4]. 
Although conventional pulmonary angiography has great value in PE diagnosis, it suffers 
from being expensive, invasive with serious side effect, requiring expertise and supporting 
staff, and not readily available in most hospitals.
Vascular Doppler ultrasound is a quick, noninvasive, and reliable technique [23]. It is painless 
and carries no risk. However, it provides less clinical information (e.g., number of clots and 
amount of obstruction) than other imaging techniques and very dependent on the experience 
of the examiner [4, 23].
Finally, several reports showed promising results for the assessment of PE with magnetic 
resonance imaging (MRI) [24, 25]. This modality is promising because images can be gener-
ated without radiation, and because it allows a combination of morphological and functional 
imaging (e.g., perfusion). However, MR has a lower spatial resolution than CT and much 
longer acquisition times (around 30 min as opposed to seconds in CT).
2.6. Treatment
Untreated PE can be fatal with high mortality rate that can be decreased under rapid detection 
[6]. There are ranges of different types of treatment procedures [4]. They include hemodynamic 
and respiratory support, anticoagulation medications, thrombolytic therapy, surgical embo-
lectomy, percutaneous catheter-directed therapy, and venous filter intervention, which are not 
without complications. The selection of treatment depends on the PE severity and prognosis. 
Generally, the obstruction is mild when only a few subsegmental vessels are blocked and it 
is severe when multiple segmental or a few lobar vessels are blocked. Mild PE is managed 
with clot-dissolving medication. Severe PE requires additional medical intervention, such as 
placement of a filter in the inferior vena cava, or clot removal with either a catheter or surgery.




This section introduced clinical facts of pulmonary embolism. This includes concise of PE’s 
epidemiology, predisposing factors, pathophysiology, classifications, and treatments proce-
dures. The available diagnostic medical imaging systems, which are the decision-makers of 
the presence and severity of PE, were explained with their strengths and limitations, rational-
izing the shift toward the use of CT.
3. Computerized tomography pulmonary angiography (CTPA)
Computerized tomography pulmonary angiography (CTPA) is a multidetector computerized 
tomography (MDCT) scanner that acquires cross-sectional chest images during the adminis-
tration of contrast agent [10]. This permits the visualization of the blood flow in pulmonary 
veins and arteries. This section describes the CTPA technology and its impact in diagnosing 
PE. Aspects covered include: (1) the basic of CTPA technology, (2) the CTPA radiographic 
appearance, (3) the radiographic features of suspicious PE, and (4) the clinical performance of 
CTPA scans including sensitivity, specificity, and pitfalls.
3.1. CTPA technology
On CTPA, the patient’s chest is exposed by a calibrated X-ray cone beam during the injection 
of contrast media into patient, as shown in Figure 3. The X-ray photons are absorbed (i.e., 
attenuated) by various structures within the chest. The amount of X-ray attenuations varies 
with accordance to the type and density of the tissues in the chest. The maximum absorp-
tion occurs in the dense bone and sites of contrast agent (i.e., pulmonary vessels); while the 
minimum absorption happens in the lung (i.e., air); the other thorax tissues (i.e., the heart, 
the muscles, and the upper parts of abdomen) lay in between those two structures. The X-ray 
Figure 3. Four rings MDCT technology (there are 256 rings in modern MDCT).
Angiography120
cone beam rotates 360 degrees around the patient. At each angle, the penetrated X-ray beam 
from patient strikes rings of X-ray digital detectors. The detectors measure the amount of 
X-ray absorption and then fed to computer which, in turn, processes these data to reconstruct 
a CTPA three dimensional (3D) volumetric radiographic data of the chest’s tissues. The CTPA 
image quality is governed by set of technical parameters; the interested readers may revise 
one of the MDCT books such as the book by Seeram in Ref. [26].
The volume of contrast media depends on patient weight, and may vary in [40 mL, 140 mL], 
also based on the dye concentration. Iodine is commonly used because of its relatively harm-
less interaction with the body and its solubility; the concentration is usually 250–350 mg/mL. 
Generally, a 4 or 5 mL/s is injected through a catheter in an antecubital vein. The rate of injec-
tion may increase in the advanced generations of MDCT, when acquisition time decreases in 
order to maintain sufficient iodine concentration within the vessels. The contrast peak hap-
pens after 10–25 s depending on the patient. Ideally, the scan should be complete before the 
radiographic dye reaches the left ventricle in the heart, as this may mean contrast has drained 
from the pulmonary arteries, or require a larger dose of contrast media.
3.2. CTPA radiographic appearance
The CTPA 3D radiographic data are displayed in three orthogonal views (i.e., Digital images); 
these are the two dimensional (2D) axial, sagittal, and coronal cross sections (Figure 4). In 
each CTPA view, the pixel brightness (2D picture element) is proportional to amount of X-ray 
absorption at tiny 3D cube (i.e., voxel) in the patient’s chest.
Understanding the radiographic CTPA appearance is important during the detection of 
PE. The lung parenchyma exhibits the lowest X-ray absorption so it appears as “black” regions 
clearly delineating the borders of lungs in the CTPA view. The soft tissues (i.e., the heart, 
muscles, fat, and upper constituents of the abdomen) appear as a radiolucent area (lower 
X-ray absorption). These regions appear in a form of various radiographic shades of gray lev-
els (i.e., various optical intensities). On contrast, the regions of bones and the contrast agent in 
the pulmonary vessels are radio-opaque (higher X-ray absorption) and appear as bright (i.e., 
white) regions. Figure 4 demonstrates the radiographic appearance of these different tissues 
where the contrast agent (indicated by red letters “CA”) looks brighter than the surrounding 
lung parenchyma, while remaining thorax constituents look with various intensities.
Figure 4. The three CTPA orthogonal views radiographic appearance (axial, sagittal, coronal).
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3.3. PE radiographic features
The contrast medium opacifies the bloodstream in the lung. In case of PE, the pulmonary 
vessel is either completely blocked, or passes around it. Thus, on CTPA view, the veins and 
arteries appear white where the bloodstream is present, and a thrombus can be observed as 
a dark spot inside the white mass. Figure 5 (left) illustrates examples of acute and chronic PE 
affecting the left main PA and right lobar artery, respectively. Acute thrombi appear as a hole, 
or concavity, in the vessel, while chronic clots are found on the edge of the vessel, with no 
concavity. Figure 5 (right) also shows example of peripheral clot (segmental).
3.4. Clinical performance of CTPA scan
The radiologist navigates the CTPA slices searching the presence of a clot. The diagnosis of 
PE is categorized in a yes-or-no decision, independent of the location and severity of emboli. 
When a defect (clot) is found in one slice, the adjacent neighbors are analyzed. The radiologist 
tracks the clot to the point where she/he knows for sure its anatomical location in the pulmo-
nary vascular veins and arteries and assesses his/her conclusion. Sensitivity and specificity 
are two statistical parameters commonly used to evaluate any diagnostic test. In this subsec-
tion, these two parameters are introduced in association with CTPA examination. This leads 
to the discussion of the CTPA artifacts.
3.4.1. Terminology background
Let us suppose that a population of patients, pathologically proved to have or not to have 
PE, was asked to undergo CTPA examination. Then, radiologists are asked to interpret these 
CTPA scans. The correct interpretation of a CTPA scan can be either a true-positive (TP) 
response (i.e., the correct detection of clots) or a true-negative (TN) response (i.e., the correct 
decision that there is no clot). In contrast, the false interpretation of a CTPA scan is described 
as either a false-positive (FP) response (i.e., the false suggestion of PE that does not exist) or 
a false-negative (FN) response (i.e., the PE is missed). These four possible categories of CTPA 
interpretation are illustrated in Table 1.
The proportion of TP responses to the total number of pathologically proven PE patients is 
referred as the true-positive fraction (TPF) or the sensitivity (the ability to detect patients with PE). 
Figure 5. Examples of chronic and acute PE (left), and segmental PE (right) appearance on CTPA image.
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It is calculated as the ratio of TPs to the sum of FNs and TPs as illustrated in Eq. (1). On the other 
hand, the proportion of TN responses to the total number of patients, which do not have PE, is 
called the true-negative fraction (TNF) or specificity (the ability to exclude patients without PE). It 
is calculated as the ratio of TNs to the sum of FPs and TNs as illustrated in Eq. (2).
  sensitivity = TPF =  TP ______ 
TP + FN
(1)
  specificity =  TN ______ 
TN + FP
(2)
  FPF =  FP ______ 
TN + FP
 = 1 − specificity (3)
Consequently, sensitivity measures the reader’s performance in detecting patients with 
clots, whereas specificity measures the reader’s ability to avoid producing false responses. 
Specificity is usually derived from the false-positive fraction (FPF) as shown in Eq. (3). Also, 
the predictive value of a positive test PV(+) and the predictive value of false test PV(−) can 
be evaluated as in Eqs. (4) and (5). These are also alternatively referred as positive predictive 
value (PPV) and negative predictive value (NPV). As FP and FN increase (i.e., increment in 
interpretation mistakes), the PPV and NPV decrease.
  PV (+)  =  TP ______ 
TP + FP
(4)
  PV (−)  =  TN ______ 
TN + FN
(5)
3.4.2. CTPA’s sensitivity, specificity, and negative and positive predictive value
Early investigations were reported in the 1990s regarding the impact of CTPA examinations in 
detecting PE. The results of these reports were reviewed by Rathbun in 2000 [27] and Hiorns 
in 2002 [28], showing that the sensitivity and specificity of CTPA may vary between the range 
of 51–100 and 81–100%, respectively. These initial results revealed the possibility of MDCT to 
diagnose PE.
Over the last decade, the clinical role of CTPA examination has undergone extensive scientific 
investigations [7–10]. The largest and most significant collaborative clinical trial was conducted 
in 2006 [10]. This study is well-known as PIOPED II (Prospective investigation of pulmonary 
CTPA truth information
Radiologist decision Abnormal (PE exists) Normal
Abnormal True positive (TP) False positive (FP)
Normal False negative (FN) True negative (TN)
Table 1. Outcomes of radiologist interpretation of CTPA examinations.
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embolism diagnosis, second study). The dataset consisted of 824 patients who had enrolled 
for CTPA examination in the period 2001–2003 using 4, 8, and 16 rows MDCT devices. These 
CTPA scans were interpreted by different radiologists at remote clinical centers (i.e., hospitals) 
in the USA and Canada. The study reported sensitivity (i.e., the proportion of correct diagno-
sis of patients with PE) of 83% and specificity (i.e., the proportion of the correct diagnosis of 
patients without PE) of 96%. The high value of sensitivity means high TP and low FN (Eq. (1)), 
while high value of specificity means high TN and low FP (Eq. (2)). Based on the PE probability 
is low, intermediate, or high, the PPV and NPV was 58 and 96%, 92 and 89%, and 96 and 60%, 
respectively. On the other hand, based on the PE location is lobar, segmental, or subsegmental 
vessels, the PPV was 97, 68, and 25%, respectively. The defects at extreme sites of pulmonary 
vascular branches (segmental and subsegmental vessels) exhibit less observability, and conse-
quently more challenging to radiologists, than lobar and main PA clots.
A recent report, in 2015, was published by Dogan et al. in the Netherlands; this study reviewed 
different CTPA clinical trials and reported that the sensitivity and specificity of CTPA scans 
may vary between the range of 83–100% and 89–96%, respectively [8]. The NPV was 96–99% 
showing the high CTPA scan’s certainty in ruling out PE; a negative CTPA can safely exclude PE. 
Estrada-Y-Martin and Oldham supervised a survey regarding the clinical practice in the diag-
nosis of PE in USA [9]. The survey included members (i.e., Intervention Radiologists) of the 
Society of Thoracic Radiology (524 members) and the Society of Interventional Radiologists 
(389 members). The surveyed members believed that CTPA examination is the gold standard 
to diagnose PE. This conclusion sustained previous study emphasizing that CTPA is the first-
line imaging for the evaluation of PE [7]. These clinical trials and surveys have resulted in the 
worldwide acceptance of CTPA as the best method for the detection of PE.
3.4.3. CTPA artifacts
Although the clinical reports accepted CTPA as best-reliable method with high sensitivity for 
diagnosing PE, their results also showed that FNs diagnosis, which are potentially life-threat-
ening or a prospective health burden, may occur. For a radiologist, it can be difficult to detect 
all PE in the CTPA data [4, 10] for several reasons. In CTPA clinic, the radiologist is asked to 
examine stack of high resolution 2D CTPA images for single patient. Each 2D CTPA image is a 
512 by 512 pixels. The stack builds a 3D CTPA volume of voxels (volume pixels), of which the 
size, in modern MDCT devices, is approximately 0.6 mm in every direction. Thus, a CTPA scan 
consists of millions of voxels have to be reviewed. Furthermore, the segmental and subseg-
mental vascular branches are quit complex; it is impossible to visualize all vascular structures 
within one CTPA image at a time. Therefore, radiologists usually revise the 3D CTPA volume 
several times examining only parts of the vascular system in the attempt not to miss an intra-
vascular (sometimes very small) black dot indicating PE. A secure detection or exclusion of PE 
is therefore quite time-consuming and dependent on the experience of the radiologist.
Additionally, diagnostic pitfalls may occur due to CTPA artifacts [29, 30]. Some artifacts leads 
to defects that imitate PE; this may include a poorly filled vein with contrast media, lymphoid 
tissue around the vessels, impacted bronchi mimic dark tubular structures, or parenchymal 
diseases altering pulmonary perfusion. Technical factors may also lead to artifact hampering 
the correct PE diagnosis; this include image noise due to low dose or obese patients, respiratory 
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or cardiac motion leading to inhomogeneous intravascular contrast, streak-artifacts near the 
superior vena cava due to beam hardening, incorrect timing resulting in insufficient intra-
vascular contrast, or artifacts due to edge-enhancing image reconstruction. Further details of 
these artifacts are explained in MDCT technical books such as the reference number [26].
3.5. Summary
This section explained the CTPA practice. The CTPA basic physics, technology, examination, 
and radiographic appearance of PE and other thorax tissues were explained. The sensitivity, 
specificity, and PPV and NPV of CTPA are outlined based on clinical trials and surveys in the 
last two decades. These reports concluded that that CTPA remains, at the time, as the first line 
diagnostic procedure providing the less invasive procedure, and highest sensitivity, specific-
ity, and NPV among other imaging techniques. The CTPA artifacts, which may contribute to 
misdiagnosis, were mentioned.
4. Computer-aided detection of PE on CTPA views
It is difficult and time consuming for a radiologist to navigate all CTPA orthogonal slices and 
find all emboli, this also depends on the radiologist experience. In PIOPED II, which was held 
at well-estimated clinical institutes, the average of 9.3% FP and 2.4 FN responses were reported 
[10]. This means that among 1000 suspicious PE patients, which is a daily small number of CTPA 
examination in any developed country, 93 patients may incorrectly diagnosed as having PE and 
may be asked to undergo further clinical tests, which is a clinical burden and probably additional 
X-ray radiation dose. Also, which is more critical, 24 patients may be incorrectly excluded of 
having PE and would leave the hospital without considering medication; these patients would 
be left under serious medical consequences that may be fatal. It is important to note again that FP 
and FN depend on radiologist experience, for example, in PIOPED II, it is possible for the NPV 
and PPV to be 58 and 60%, respectively. This lack of imperfection diagnosis may attribute to 
many reasons as explained in Section 3.4.3. Therefore, a computer-assisted detection (CAD) for 
the diagnosis of PE is desirable. This section aims to describe the CAD technology then explains 
the current state of how PE-CAD can contribute in improving patient health in CTPA clinic. This 
leads to explain the comments on CAD and the necessary recommendations. Comprehensive 
information on CAD technology in medical imaging can be found in Ref. [31].
4.1. CTPA-CAD definitions
A computer-aided detection (CAD) algorithm is an architecture of computer image analy-
sis processes that yield, when applied to a CTPA examination, to the prompting of regions 
of suggestive pulmonary obstruction such as the presence of clots. Such prompting is often 
used as a “second opinion” to alert the radiologist to structures that, otherwise, might be 
overlooked [2, 3]. Figure 6 shows a CTPA slice (left) and the responses of the CTPA-CAD 
(right), which are indicated as red overlay. They are also called as CAD stimuli, candidates, or 
outputs. These CTPA-CAD responses are categorized to one of four possible groups, similarly 
to those explained in Section 3.4.1 describing the radiologist accuracy in interpreting CTPA 
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scans. They are: the TP, FP, TN, FNs groups. Figure 6 (right) illustrates TP (i.e., correct prompt 
of clot) and FP (incorrect prompt of clot) stimuli, indicated with red and green arrows, respec-
tively. There are two clots that were not prompted, so they are FN stimuli, which are indicated 
with blue arrow. The remaining pulmonary vessels, which were not prompted as PE, are the 
TN stimuli. As with radiologist, it is desirable that a CTPA-CAD algorithm leads to the high-
est TP and TN, while it yields the lowest possible FP and FN stimuli.
The performance of the CAD software can be tested “per clot” or “per patient” basis. For 
“per clot” basis, the CTPA-CAD responses are counted in comparison to truth of all actual 
PE occurrences (i.e., all clots) in the CTPA examination. While for “per patient” basis, it is not 
important for the CTPA-CAD to find all thrombi. Additionally, the CTPA-CAD responses can 
be evaluated on “first reader” or “second reader” basis. The “first reader” analysis, which is 
also called as “standalone performance,” refers to the outcomes of the CTPA-CAD software 
in a defined dataset of clinical CTPA scans without interference of radiologists. The “second 
reader” performance means that the CTPA-CAD output is utilized to support the radiologist 
decision after he/she has assessed the examination primarily unassisted and uses the results 
of CTPA-CAD only to refine his/her judgment.
As explained in Section 3.4, in current clinical CTPA practice, the diagnosis of PE is divided 
in a yes-or-no decision, regardless to the colts’ number, location, and severity of emboli [4]. It 
is, therefore, less important that a CTPA-CAD system finds all emboli in a CTPA scan. More 
significant tasks of CTPA-CAD seem to be: to increase the radiologist’s certainty to rule in or 
out PE (i.e., improve sensitivity and specificity), to reduce the CTPA interpretation time, and 
to decrease inter-reader variability [2, 3]. Thus, most researchers prefer the “per patient” basis 
to evaluate the performance of CTPA-CAD because it is more clinically relevant than the “per 
clot” basis.
4.2. CTPA-CAD performance
The first study on a CTPA-CAD algorithm was published in 2002 by Masutani et al. [32] for a 
group of 19 high-quality CTPA examinations; they reported a sensitivity on a per clot basis of 
100% with 7.7 false-positive findings per examination. Since then, numerous methods, utiliz-
ing various image analysis concepts, have been tested by different vendors and image analysis 
groups. Some CTPA-CAD algorithms have attained clinical merit, while some are still under 
development. This section reviews the performance of these methods, dividing them into two 
Figure 6. Types of assessment of CTPA-CAD stimuli on CTPA image.
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groups. The first group describes the marketable CTPA-CAD available from famous vendors 
such as SIEMENS, PHILIPS, and GE. The second group describes underconstruction CTPA-CAD 
software. In general, the review focuses on the main image analysis aspects implemented in the 
CAD algorithm (if it was disclosed), the method’s performance, size of dataset, and the charac-
teristics of CTPA images, particularly the slice thickness that has direct impact on diagnosing PE.
4.2.1. Commercial CTPA-CAD
These are the CTPA-CAD methods that were developed at famous medical imaging vendors, 
for example, Philips (Philips Healthcare, Best, The Netherlands), Siemens (Siemens Medical 
Solutions, Germany), and GE (General Electric Healthcare, USA). They have been FDA approved 
and tested in a clinical environment. Since they are offered in the medical imaging market, the 
methodology (i.e., sequence of image analysis aspects) is not disclosed. This subsection presents 
the reports explaining their clinical performance “first reader” or “second reader” basis.
For CTPA-CAD made by Philips, two clinical trials by Wittenberg et al. [33, 34] and one by 
Lahiji et al. [35] were reported. The first trial by Wittenberg et al. was in 2010; they tested the 
CAD output on 225 negative and 67 positive CTPA scans (292 retrospective scans) acquired 
from 16 and 64 MDCT devices with 0.9 or 1 mm slice thickness [33]. For “first reader” basis, the 
results showed 94 and 21% sensitivity and specificity, in turn. The rate of FP stimuli was 4.7 per 
examination. The NPV was 92% indicating possibility to serve as reassurance for less experi-
enced readers. The CAD also found seven FN scans, two at segmental and five at subsegmen-
tal vessels. The second trial was published in 2012 [34]. They examined the performance of six 
radiologists with and without the CTPA-CAD on 158 negative and 51 positive retrospective 
CTPA scans, which were obtained from 16 and 64 MDCT devices with 0.9 or 1 mm slice thick-
ness. For “second reader” basis, there was no significant change in specificity, but the sensitiv-
ity increased in the range from 12% (expert reader) to 12 (radiologist-in-training or less expert). 
The rate of FP was 4.9 per scan. Lahiji et al., in 2014 [35], evaluated 26 negative and 40 positive 
CTPA scans from 256 MDCT device with 0.9 mm slice thickness. Although their study was to 
compare two different CTPA image reconstruction algorithms (the iterative and filtered back 
projection techniques), a CTPA-CAD software was used for the assessment. For “first reader” 
basis, the reported sensitivity and specificity for both image reconstruction techniques were in 
the range 85–97.2 and 26.9–61.5, respectively. The rate of FP was in the range 1.5–3.6.
For CTPA-CAD made by Siemens, Lee et al. studied 16 negative and 21 positive CTPA scans 
acquired from dual energy CT angiography (DCTA) with 1.2 mm slice thickness [36]. When 
both readers used the CAD prototype, the sensitivity was improved by approximately of 5% 
without significant loss in specificity. The rate of FP was 3.5 per examination. Blockmon et al. 
evaluated 79 CTPA scans (36 positive and 43 negative) from 16 and 64 CTPA devices at 1 mm 
slice thickness [37]. The radiologists, without the aid of CTPA-CAD, scored 84.4 and 92.6 
sensitivity and specificity, in turn. For “first reader” basis, the CTPA-CAD achieved 93.8% 
sensitivity and 14.9% specificity; while it achieved 92.2% and 88.3% for “second reader” basis. 
The FP rate was 3.5 per scan. Earlier study was by Engelke et al. in 2008 [38]. They studied 56 
positive CTPA scans obtained from 64 MDCT device with 0.6-mm slice thickness. On “sec-
ond reader” basis, the four readers reported no significant loss of specificity while sensitivity 
increased in the range 3–7%. The FP rate was 4.1 per scan.
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Wittenberg et al. compared the performance of three different CTPA-CAD systems made 
by Philips, GE, and Siemens [39]. They studied three groups of CTPA scans from 64 MDCT 
devices made in Philips, GE, and Siemens with 0.6, 0.9, and 1.5 mm slice thickness, in order. 
The three groups of dataset contained 38, 39, and 38 positive CTPA scans; it also contained 40, 
40, 37 negative CTPA scans, respectively, according to each CTPA group. For “first reader” 
basis, the comparison yielded a sensitivity of 100, 97, and 92, specificity of 18, 15, and 13, and 
FP rate of 4.5, 6.2, and 3.7, respectively, to each group.
Table 2 summarizes the results of previous trials of different CTPA-CAD systems from differ-
ent vendors. For comparison, the table also includes the results from PIOPED II (the largest 
clinical trial) explained in Section 3.4.2. The table illustrates the CTPA clinical performance 
once CTPA images are interpreted by the radiologist, the CTPA-CAD software (CAD first 
Reader basis), consensus between radiologist and the CTPA-CAD software (CAD second 
reader basis). The table consists of 7 main columns. The first column shows the author with 
the reference number. The second column indicates the interpretation procedure type (radi-
ologist, the CTPA-CAD software, consensus of Radiologist and the CTPA-CAD software). The 
third column demonstrates the dataset’s size indicating the number of positive and negative 
CTPA scans. The fourth, fifth, and sixth column indicate the performance in term of sensitiv-
ity, specificity and rate of FP, in order. Finally, the last column shows slice thickness used to 
acquire CTPA image. Table 3 shows the range values of the sensitivity, specificity, and FP rate 
for each diagnosis protocol, which are reported in Table 2.
The findings listed in Tables 2 and 3 indicate the following:
1. If CTPA scan is interpreted by radiologist only, the sensitivity and specificity may not 
reach 100%. The sensitivity range from 77.7% (for radiologist-in-training or less experi-
ence) to 94% (expert radiologist). While the specificity varies in the range 89–98% indi-
cating almost perfect performance in excluding PE. The 100% specificity reported by Lee 
et al. [36] (Table 2) was reported on small number of negative CTPA scans, so it cannot be 
generalized.
2. For CTPA-CAD “first reader” basis, the marketable CTPA-CAD methods can score reliable 
high sensitivity, which can exceed the performance of an expert radiologist. However, 
the specificity is low (~20% in all reports in Table 2) due to 3.4–4.9 FP stimuli per CTPA 
scan. The 61.5 specificity reported by Lahiji et al. [35] is concluded from applying iterative 
reconstruction that is under research.
3. For CTPA-CAD “second reader” basis, the CAD can improve radiologists’ sensitivity up 
to 7%. This increment in sensitivity coincides with no significant change in specificity. This 
enhancement can be substantial for inexperienced radiologist as reported by Wittenberg 
et al. [34], which one of the radiologists scored 90% with the aid of CTPA-CAD in compari-
son to 78% without the CAD assistance.
4. The results were obtained on different MDCT devices, thus the performance of CTPA-
CAD is independent of scanner type. However, it is relevant to image quality and scanning 
protocols such as slice thickness. Actually, the slice thickness has significant impact on 
PE diagnosis. For example, Jung et al. [40] analyzed 15 positive and 25 negative CTPA 
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Table 2. “Per patient” CTPA interpretation by the radiologist, “first reader” marketable CTPA-CAD software, and 
“second reader” CTPA-CAD software, showing sensitivity, specificity, rate of FP responses, and the characteristics of 
dataset used in the clinical trials.
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slice thickness increases, there was significant decrease of PE diagnosis of lobar, segmen-
tal, subsegmental clots on both the axial and coronal CTPA views. They concluded that a 
slice thickness of 1 mm is a must to achieve high sensitivity, particularly the subsegmental 
PE. This impact is applicable to CTPA-CAD and must be considered in any CAD prototype 
[2, 3]. This matter, among other variables, is further described in Section 4.3.
Consequently, the marketable CTPA-CAD software can increase reader sensitivity for the 
detection of PE, particularly the segmental and subsegmental pulmonary clots, and enforce 
reader confidence for the diagnosis of PE without significant loss of specificity. This rise in 
sensitivity means less FN CTPA scans (Eq. (1)), thus improving patient health.
4.2.2. Underconstruction CTPA-CAD
There are nonmarketable CAD systems under construction by researchers. They share the 
employment of CTPA pulmonary vessels segmentation, candidate clot detection, and texture 
and feature computation with/without morphology analysis on 2D and 3D levels. However, 
they explored recent advances in computer sciences to reduce the FP rate such as complex 
mathematical classifier [41–43] and artificial intelligence (e.g., neural networks) [44, 45]. Thus, 
they reported their results on “per clot” basis.
The results in Table 4 demonstrate that the “per clot” CTPA-CAD’s sensitivity is in the range 
from 63–80%. This qualifies those CAD prototypes to be tested on “per patient” basis. However, 
the rate of FP stimuli is still high, so a low specificity value, as those in Table 2, is again very likely 
to happen. False-positive stimuli are the main burden hindering radiologist from accepting the 
CTPA interpretation protocol Sensitivity (%) Specificity (%) FP rate per scan
Radiologists 77–94 89–98 —
CAD (Philips, Siemens, or GE) 85–100 13–61.5 1.5–6.2
Consensus between radiologist and CAD (Philips, Siemens, 
GE)
84–96 88.3–100 3.5–4.9
Table 3. “Per patient” range of the values of sensitivity, specificity, rate of FP responses, based on each protocol of CTPA 
interpretation.
Author Number of clots in CTPA cases Sensitivity (%) FP rate per scan
Bouma [41] 318 in 57 positive CTPA 63 4.9
Zhou [42] 595 in 59 positive CTPA 80 22.6
Zhou [43] 537 in 50 positive CTPA (PIOPED II) 80 8.6
Park [44] 44 in 18 positive CTPA 63.2 18.4
Tajbakhsh [45] 326 in 121 positive CTPA 83 2
Table 4. “Per clot” sensitivity and FP rate for underconstruction CTPA-CAD prototypes.
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superfluous sensitivity of CTPA-CAD. To reduce the FP rate, Tajbakhsh [45] employed 3D pre-
sentation of PE and blood vessels, coupled to neural network, to produce 2 FP per CTPA scan 
(Table 4). Al-hinnawi et al. [46] suggested another 3D technique, but simpler than neural net-
works that requires training and calibration on dataset characteristics, to reduce the FP rate. In 
the final step of their CTPA-CAD system, the stimuli from three CTPA views were orthogonally 
recombined to produce a single interactive 3D display of PE candidates from the CTPA case, as illus-
trated in Figure 7. Thus, this would permit, in a single analysis instead of slice by slice analysis, 
the assessment of CAD performance on the aggregated CAD responses on the three CTPA views 
of each patient. This could reduce time, and consequently reduce burden to radiologist. Clots 
that are bigger in size than 1 mm3 were retained based on the voxel size of the CTPA scan. Thus, 
the CAD system can be tuned in accordance with the variations in CTPA acquisition settings 
due to patient differences, which was not employed in previous marketable CTPA-CAD sys-
tems or underconstruction CTPA-CAD prototypes. This reduces the variations in CAD outputs 
due to variation in patient preparation such as slice thickness. They reported that this approach 
would reduce the FP rate of from CAD systems, such as those in Tables 2 and 4, by 30% while it 
increases or ascertains the correct rate of CTPA-CAD’s TP stimuli as much as 27%.
4.3. Factors affecting CTPA-CAD performance
CTPA-CAD systems are image quality dependent [2, 3, 47, 48]. As for any X-ray imaging 
technique, the CTPA image quality is ruled by factors related to subject variance, acquisition 
parameters, patient preparation, and dose management [4, 49]. The subject variances such as 
Figure 7. Three dimensional visualization of CTPA-CAD output (courtesy from radiological physics and technology no. 
JSMP30–180024).
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age, sex, race, presence of risk factors, prevalence and morphology of the clots, they do not 
have impact on CTPA image quality; so they should not influence the CTPA-CAD outcome. 
Thus, there is no need to calibrate the CAD system based on different patients or countries.
However, the acquisition and patient preparation variables are fundamental factors in CTPA 
image quality. They may lead to bias in the CTPA-CAD output [2, 3, 47–49]. Acquisition 
parameters include KV, mA, type of reconstruction algorithm, accurate MDCT window, and 
any post processing filtration, among other technical parameters, they all affect CTPA image 
contrast. On the other hand, patient preparation include mainly the slice thickness, correct 
contrast agent dose and rate of injection, and accurate timing to acquire CTPA images during 
the pulmonary vessels are filled with contrast agent not after it drained to heart, they all affect 
the precise depiction of clots with variable sizes and locations [4, 7, 10, 40]. While radiologist, 
and the clinical physicist or radiographer, may be relatively unaware to such factors, it is 
believed for sure that they have direct impact on CAD systems because they lead to altera-
tions in the representation of radiographic features on which CAD relies [2, 3, 48, 50].
Dose management also has crucial role on any CAD output. As reducing X-ray dose is main 
concern in imaging, different vendors provide imaging protocols and reconstruction techniques 
to reduce patient dose without substantially risking the image quality. These ultra-low dose, 
or even low dose, settings lead to lower contrast to noise ratio, which in turn leads to higher 
possibility to CT artifacts and lower capability to spot diseases [51–53]. These parameters are 
relevant to any CAD system [2, 3, 47, 48], so can greatly affect the PE CAD performance.
4.4. CTPA-CAD recommendations
Therefore, subsequently to the discussion mentioned earlier, the CTPA-CAD manufactures 
should clearly describe the operating characteristics of their PE CAD prototypes. This include, 
the supported range of equipment, CTPA image acquisition settings, patient preparation 
requirements, reconstruction algorithms, and patient special cases such as those with addi-
tional lung defects, among other relevant factors, that radiologist need to be aware during 
the use of CTPA-CAD. Additionally, in case of CTPA-CAD comparison with findings from 
previous CTPA scans is used to assess decisions on diagnosis, disease progression, and/or 
treatment effectiveness, care must be considered to match the acquisition conditions accord-
ingly to CTPA-CAD operating manual [2, 3, 47–53].
4.5. Summary
This section described the current status of utilizing PE CAD prototypes in CTPA clinic. The 
necessity of CAD systems in PE diagnosis is highlighted, and different possible CAD group 
of outputs are explained. Then, according to research centers from different countries, the 
performance of marketable and underdevelopment CTPA-CAD systems is elucidated. The 
PE CAD performance can be described according to “per clot” or “per patient” basis, and 
“first reader” or “second reader” basis. The “per patient” basis is more relevant to CTPA 
clinical practice than “per clot”. Both the “first reader” and “second reader” basis lead to 
high sensitivity that can reach 100%, outweighing the radiologist performance. However, the 
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specificity drops dramatically and become much less than the radiologist performance in case 
of “first reader” basis. Studies showed that the best operating scenario is the “second reader” 
basis because it improves sensitivity, which means less FN results, while it guarantees no 
significant change in specificity, in comparison to human observer performance. The factors 
affecting the CTPA-CAD output were described at the end of this section, this yielded to sug-
gest recommendation.
5. Conclusion
This chapter presents comprehensive current status knowledge in the PE angiography clinic. The 
clinical proofs of thrombosis are explained in Section 2. Knowledge of PE epidemiology, pre-
disposing factors, pathophysiology, classifications, diagnostic medical imaging modalities, and 
treatments procedures are described. Then, in Section 3, concentration is focused on describing 
the CTPA technology that is the clinically accepted as the best first-line imaging procedure in 
PE diagnosis because it is fast, lowest invasive, and the highest sensitivity procedure, among 
other medical imaging modalities. Issues covered are CTPA physics, technology, examination, 
radiographic appearance, and PE features, the clinical trials in term of sensitivity, specificity, 
PPV, and NPV, are explained. Section 4 provides demonstration of the art of CAD system and 
their influence on improving the PE diagnoses by being eligible to reduce miss diagnosis by 
radiologist. Advantages and disadvantages of assessing CTPA-CAD performance with regard 
to “per patient”, “per clot”, “first reader”, and “second reader” basis are explained. Results 
suggested that the “second reader” along with “per patient” basis is the best scenario to utilize 
PE CAD systems, because this raises the sensitivity without effect on specificity of radiologist 
performance. Precautions and recommendations of optimal practice of PE CAD prototypes are 
described indicating the necessity to follow the operation manual specifications, particularly 
the CTPA acquisition parameters and patient preparation, which the CAD relies on.
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